Friday, July 20, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Six-Time Gold Medalist Amy Van Dyken Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team
Former Olympic Swimmer to Spread Awareness on Benefits of CBD
(July 12, 2018)

SAN DIEGO, July 12, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that six-time Olympic gold medalist Amy Van Dyken has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of cannabidiol (CBD) for athletes, former athletes and those who are just looking to lead a healthy, active lifestyle.

"We're thrilled to work with Mrs. Van Dyken and to continue the conversation about the benefits that former athletes like her are experiencing from using CBD," said Kannaway® CEO Blake Schroeder. "Her personal story is a perfect example of how CBD not only can improve a person's life, but also enable them to continue living the active lifestyles they have grown accustomed to."

Kannaway® is the first hemp lifestyle network to legally offer hemp-based botanical CBD wellness products. Its Kannaway® Sports division is connecting athletes with the education and products they need to help them live happier, more fulfilling lives. Kannaway® announced June of 2018 as its largest-ever (unaudited) sales revenue month in its history and that the Company has grown more than 50 times in revenue under new management since 2016.



"Kannaway's CBD products have drastically improved my quality of life. I was skeptical at first, but Kannaway Pure CBD is making my life enjoyable again," said Van Dyken. "I take two tablespoons of the Kannaway Pure CBD in my coffee every morning and I feel like a new person. I hope my story can help spread awareness of the benefits of CBD so that people like me can feel more comfortable giving it a try."

"It is an honor to work with individuals like Amy Van Dyken who share the same goal of increasing education and awareness of CBD as a safe dietary supplement," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We hope this partnership will help clear up the many misconceptions people have about cannabis and CBD."

About Kannaway®  
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
[email protected]
www.cmwmedia.com

 

Cision View original content:http://www.prnewswire.com/news-releases/six-time-gold-medalist-amy-van-dyken-joins-medical-marijuana-inc-subsidiary-kannaway-sports-team-300679871.html

SOURCE Medical Marijuana, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Video,USA, Inc.,Diet,Disease,Surgery,Sports,Lifestyle,Sports,Olympics,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines